Bajad NG

References (3)

Title : Development of multi-targetable chalcone derivatives bearing N-aryl piperazine moiety for the treatment of Alzheimer's disease - Bajad_2024_Bioorg.Chem_143_107082
Author(s) : Bajad NG , Singh RB , T AG , Gutti G , Kumar A , Krishnamurthy S , Singh SK
Ref : Bioorg Chem , 143 :107082 , 2024
Abstract :
PubMedSearch : Bajad_2024_Bioorg.Chem_143_107082
PubMedID: 38199142

Title : Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease - Gutti_2023_Eur.J.Med.Chem_259_115670
Author(s) : Gutti G , Leifeld J , Kakarla R , Bajad NG , Ganeshpurkar A , Kumar A , Krishnamurthy S , Klein-Schmidt C , Tapken D , Hollmann M , Singh SK
Ref : Eur Journal of Medicinal Chemistry , 259 :115670 , 2023
Abstract :
PubMedSearch : Gutti_2023_Eur.J.Med.Chem_259_115670
PubMedID: 37515920

Title : A systematic review of carbohydrate-based bioactive molecules for Alzheimer's disease - Bajad_2021_Future.Med.Chem__
Author(s) : Bajad NG , Swetha R , Gutti G , Singh M , Kumar A , Singh SK
Ref : Future Med Chem , : , 2021
Abstract :
PubMedSearch : Bajad_2021_Future.Med.Chem__
PubMedID: 34472382